Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Adcock Ingram Holdings Ltd (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11534
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:南アフリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock Ingram Holdings Ltd (AIP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 12
Private Equity 13
Actis Rumored To Acquire Adcock Ingram For US$1.25 Billion 13
Partnerships 14
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Asset Transactions 16
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 16
Acquisition 17
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For US$393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd – Key Competitors 28
Adcock Ingram Holdings Ltd – Key Employees 29
Adcock Ingram Holdings Ltd – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Aug 29, 2018: The Adcock Ingram reports a positive trading performance 32
Corporate Communications 34
Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 34
Other Significant Developments 35
Aug 29, 2018: Adcock Ingram Holdings – Group annual results and cash dividend declaration 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 12
Actis Rumored To Acquire Adcock Ingram For US$1.25 Billion 13
EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15
Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 16
Adcock Ingram to Acquire Genop 17
Adcock Ingram Acquires Virtual Logistics 18
Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19
Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20
Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21
BB Investment Acquires 32.03% Stake In Adcock Ingram 22
Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For US$393 Million 23
Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25
Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26
Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27
Adcock Ingram Holdings Ltd, Key Competitors 28
Adcock Ingram Holdings Ltd, Key Employees 29
Adcock Ingram Holdings Ltd, Subsidiaries 30
Adcock Ingram Holdings Ltd, Joint Venture 31

List of Figures
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Adcock Ingram Holdings Ltd (AIP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioGaia AB (BIOG B):企業の財務・戦略的SWOT分析
    BioGaia AB (BIOG B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Weir Group Plc (WEIR):石油・ガス:M&Aディール及び事業提携情報
    Summary The Weir Group Plc (Weir Group) is a provider of engineering solutions. The company designs and manufactures highly engineered products and services for minerals, oil and gas, and power industries. Its products and service portfolio include pressure pumping equipment, pressure control produc …
  • Siluria Technologies Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Siluria Technologies Inc (Siluria) engaged in producing fuels and chemicals from natural gas and low value byproducts. Its products include modus - olefins to gasoline, and gemini - natural gas to ethylene. The company also involved in catalytic process to convert natural gas into liquid fue …
  • EnWave Corp (ENW):企業の財務・戦略的SWOT分析
    EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • DASAN ZHONE SOLUTIONS, INC.:企業の戦略・SWOT・財務情報
    DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report Summary DASAN ZHONE SOLUTIONS, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Torii Pharmaceutical Co Ltd (4551)-製薬・医療分野:企業M&A・提携分析
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Medicom Innovation Partner as:医療機器:M&Aディール及び事業提携情報
    Summary Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device …
  • Cleco Corporate Holdings, LLC:戦略・SWOT・企業財務分析
    Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析
    Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Shanghai Zhenhua Heavy Industry Co Ltd:戦略・SWOT・企業財務分析
    Shanghai Zhenhua Heavy Industry Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Zhenhua Heavy Industry Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Hovnanian Enterprises Inc:企業の戦略・SWOT・財務分析
    Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Hovnanian Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Mersana Therapeutics Inc (MRSN):製薬・医療:M&Aディール及び事業提携情報
    Summary Mersana Therapeutics Inc (Mersana) formerly Nanopharma Corp is a clinical-stage biopharmaceutical company that offers antibody drug conjugate to improve patients’ lives. The company offers pipeline product XMT-1522, for HER-2 targeted therapies based on its Dolaflexin platform. It utilizes F …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • Esperion Therapeutics Inc (ESPR)-製薬・医療分野:企業M&A・提携分析
    Summary Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The company’s lead product candidate, Bempedoic acid, an ATP-citrate lyase inhibitor which is in Phase …
  • Marathon Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile …
  • Golar LNG Ltd (GOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Golar LNG Limited (Golar LNG) is a midstream liquefied natural gas (LNG) company. It provides liquefaction, transport, storage, and re-gasification services to customers in the LNG industry. The company owns and operates LNG carriers and FSRUs; and develops FLNGVs. Through a joint venture wi …
  • Big Y Foods Inc:企業の戦略・SWOT・財務情報
    Big Y Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Big Y Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Parkway Pantai Ltd:企業の戦略的SWOT分析
    Parkway Pantai Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆